Cerebral haemodynamic response or excitability is not affected by sildenafil

Journal of Cerebral Blood Flow and Metabolism

Volumn 29, Issue 4, 2009, Pages 830-839

  Kruuse, Christina ^a,b   Hansen, Adam E ^a   Larsson, Henrik B W ^a   Lauritzen, Martin ^a   Rostrup, Egill ^a  

^a Mental Health Services CPH   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Magnetic resonance imaging; Migraine; Sildenafil; Vascular response; Visual evoked potentials; Women

Indexed keywords

SILDENAFIL;

ADULT; AMPLITUDE MODULATION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRAIN BLOOD FLOW; DRUG INDUCED HEADACHE; EVOKED VISUAL RESPONSE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEART RATE; HUMAN; HUMAN EXPERIMENT; HYPERCAPNIA; LATENT PERIOD; NERVE CELL EXCITABILITY; NORMAL HUMAN; PRIORITY JOURNAL; VISUAL STIMULATION;

ADULT; CEREBROVASCULAR CIRCULATION; EVOKED POTENTIALS, VISUAL; FEMALE; HEADACHE; HEMODYNAMICS; HUMANS; HYPERCAPNIA; MAGNETIC RESONANCE IMAGING; PHOTIC STIMULATION; PIPERAZINES; PURINES; SULFONES; YOUNG ADULT;

EID: 63949087842     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2009.10     Document Type: Article

References (43)

1. Arnavaz A, Aurich A,Weissenborn K, Hartmann U, Emrich HM, Schneider U (2003) Effect of sildenafil (Viagra) on cerebral blood flow velocity: a pilot study. Psychiatry Res 122:207-9
2. Ballard SA, Gingell CJ, Tang K, Turner LA, Price ME, Naylor AM (1998) Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 159:2164-71
3. Barnstable CJ, Wei JY, Han MH (2004) Modulation of synaptic function by cGMP and cGMP-gated cation channels. Neurochem Int 45:875-84
4. Bender AT, Beavo JA (2006) Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58:488-520
5. Borsook D, Burstein R, Moulton E, Becerra L (2006) Functional imaging of the trigeminal system: applications to migraine pathophysiology. Headache 46(Suppl 1): S32-8
6. Cao Y, Aurora SK, Nagesh V, Patel SC, Welch KM (2002) Functional MRI-BOLD of brainstem structures during visually triggered migraine. Neurology 59:72-8
7. Corbin JD, Francis SH (1999) Cyclic GMP phosphodiesterase-5: target of sildenafil. J Biol Chem 274:13729-32
8. Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G (2008) Posterior cerebral hypoperfusion in migraine without aura. Cephalalgia 28:856-62
9. Diomedi M, Sallustio F, Rizzato B, Ferrante F, Leone G, Spera E, Scarfini M, Bernardi G (2005) Sildenafil increases cerebrovascular reactivity: a transcranial Doppler study. Neurology 65:919-21
10. Garthwaite J (2008) Concepts of neural nitric oxidemediated transmission. Eur J Neurosci 27:2783-802
11. Giordano D, De Stefano ME, Citro G, Modica A, Giorgi M (2001) Expression of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in mouse tissues and cell lines using an antibody against the enzyme aminoterminal domain. Biochim Biophys Acta 1539:16-27
12. Goadsby PJ (2007) Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med 13:39-44
13. Hamel E (2006) Perivascular nerves and the regulation of cerebrovascular tone. J Appl Physiol 100:1059-64
14. Harvey AK, Pattinson KT, Brooks JC, Mayhew SD, Jenkinson M, Wise RG (2008) Brainstem functional magnetic resonance imaging: disentangling signal from physiological noise. J Magn Reson Imaging 28: 1337-44
15. Hoheisel U, Unger T, Mense S (2005) The possible role of the NO-cGMP pathway in nociception: different spinal and supraspinal action of enzyme blockers on rat dorsal horn neurones. Pain 117:358-67
16. Iversen HK, Olesen J, Tfelt Hansen P (1989) Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain 38:17-24
17. Kruse LS, Sandholdt NT, Gammeltoft S, Olesen J, Kruuse C (2006) Phosphodiesterase 3 and 5 and cyclic nucleotidegated ion channel expression in rat trigeminovascular system. Neurosci Lett 404:202-7
18. Kruuse C, Khurana TS, Rybalkin SD, Birk S, Engel U, Edvinsson L, Olesen J (2005) Phosphodiesterase 5 and effects of sildenafil on cerebral arteries of man and guinea pig. Eur J Pharmacol 521:105-14
19. Kruuse C, Thomsen LL, Birk S, Olesen J (2003) Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain 126:241-7
20. Kruuse C, Thomsen LL, Jacobsen TB, Olesen J (2002) The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects. J Cereb Blood Flow Metab 22:1124-31
21. Lassen L, Haderslev P, Jacobsen V, Iversen H, Sperling B, Olesen J (2002) CGRP may play a causative role in migraine. Cephalalgia 22:54-61
22. Levy D, Strassman AM (2004) Modulation of dural nociceptor mechanosensitivity by the nitric oxide-cyclic GMP signaling cascade. J Neurophysiol 92:766-72
23. Li L, Jiang Q, Zhang L, Ding G, Gang Zhang Z, Li Q, Ewing JR, Lu M, Panda S, Ledbetter KA, Whitton PA, Chopp M (2007) Angiogenesis and improved cerebral blood flow in the ischemic boundary area detected by MRI after administration of sildenafil to rats with embolic stroke. Brain Res 1132:185-92
24. Logothetis NK, Wandell BA (2004) Interpreting the BOLD signal. Annu Rev Physiol 66:735-69
25. May A, Goadsby PJ (1999) The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab 19:115-27
26. Michelakis ED, Tymchak W, Noga M, Webster L, Wu XC, Lien D, Wang SH, Modry D, Archer SL (2003) Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation 108:2066-9
27. Milman HA, Arnold SB (2002) Neurologic, psychological, and aggressive disturbances with sildenafil. Ann Pharmacother 36:1129-34
28. Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-42
29. Olesen J (2008) The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther 120:157-71
30. Pagani S, Mirtella D, Mencarelli R, Rodriguez D, Cingolani M (2005) Postmortem distribution of sildenafil in histological material. J Anal Toxicol 29:254-7
31. Pelligrino DA, Koenig HM, Albrecht RF (1993) Nitric oxide synthesis and regional cerebral blood flow responses to hypercapnia and hypoxia in the rat. J Cereb Blood Flow Metab 13:80-7
32. Pietrobon D, Striessnig J (2003) Neurobiology of migraine. Nat Rev Neurosci 4:386-98
33. Ray B, Wolff H (1940) Experimental studies on headache. Arch Surg 41:813-56
34. Rosen RC, Kostis JB (2003) Overview of phosphodiesterase 5 inhibition in erectile dysfunction. Am J Cardiol 92:9M-18M
35. Rosengarten B, Schermuly RT, Voswinckel R, Kohstall MG, Olschewski H, Weissmann N, Seeger W, Kaps M, Grimminger F, Ghofrani HA (2006) Sildenafil improves dynamic vascular function in the brain: studies in patients with pulmonary hypertension. Cerebrovasc Dis 21:194-200
36. Sand T, Zhitniy N, White LR, Stovner LJ (2008) Visual evoked potential latency, amplitude and habituation in migraine: a longitudinal study. Clin Neurophysiol 119:1020-7
37. Scheckenbach KE, Dreier JP, Dirnagl U, Lindauer U (2006) Impaired cerebrovascular reactivity after cortical spreading depression in rats: restoration by nitric oxide or cGMP. Exp Neurol 202:449-55
38. Schoenen J, Ambrosini A, Sandor PS, Maertens de Noordhout A (2003) Evoked potentials and transcranial magnetic stimulation in migraine: published data and viewpoint on their pathophysiologic significance. Clin Neurophysiol 114:955-72
39. Thomsen LL, Kruuse C, Iversen HK, Olesen J (1994) A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks. Eur J Neurol 1:73-80
40. Turgut NH, Temiz TK, Bagcivan I, Turgut B, Gulturk S, Karadas B (2008) The effect of sildenafil on the altered thoracic aorta smooth muscle responses in rat preeclampsia model. Eur J Pharmacol 589:180-7
41. Van Staveren WC, Steinbusch HW, Markerink-Van Ittersum M, Repaske DR, Goy MF, Kotera J, Omori K, Beavo JA, De Vente J (2003) mRNA expression patterns of the cGMPhydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain. J Comp Neurol 467:566-80
42. Vlachopoulos C, Tsekoura D, Alexopoulos N, Panagiotakos D, Aznaouridis K, Stefanadis C (2004) Type 5 phosphodiesterase inhibition by sildenafil abrogates acute smoking-induced endothelial dysfunction. Am J Hypertens 17:1040-4
43. Zhang R, Wang Y, Zhang L, Zhang Z, Tsang W, Lu M, Chopp M (2002) Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats. Stroke 33:2675-80